Press Releases
Information About the SEAS Study
Information About the ENHANCE Trial
Frequently Asked Questions
Home
About Us
Patient Assistance Program
Responsibility and Compliance
Company News
MERCK/Schering-Plough Pharmaceuticals

Contact Us

Thank you for your interest in Merck/Schering-Plough Pharmaceuticals.

Merck/Schering-Plough Pharmaceuticals Headquarters
351 N. Sumneytown Pike
PO Box 1000
North Wales, PA 19454

Media contact: Skip Irvine, US Public Affairs
267-305-5397